Blog

Get the latest blog updates from LabCentral sent directly to your email by subscribing here.

• Our Response to the Massachusetts Essential Services Order

  March 24, 2020 | By Johannes Fruehauf

  Like you, the LabCentral team is actively following the still rapidly developing situation with COVID-19. There is no way for us to predict…

  Read More

• LabCentral’s COVID-19 Update for Our Community

  March 18, 2020 | By Johannes Fruehauf

  As the quickly-developing COVID-19 crisis continues to bring stress and uncertainty to our resident companies, their teams and their…

  Read More

• LabCentral’s Measures in Response to COVID-19 for Our Community

  March 10, 2020 | By Johannes Fruehauf

  Disclaimer: The views, thoughts, and opinions expressed in this blog belong solely to the individual author, and not…

  Read More

• Resident Company Profile: Angiex

  January 09, 2020 | By Lindsay Crockett

  We’re excited to launch a new blog series profiling LabCentral resident and alumni companies to showcase the entrepreneurs, scientists,…

  Read More

• Biopharma Has Abandoned Antibiotic Development

  December 12, 2019 | By Isaac Stoner

  Biopharma Has Abandoned Antibiotic Development (Here’s Why We Did, Too) Disclaimer: Isaac Stoner is the President and COO of…

  Read More

• The Drug Pricing Debate

  September 23, 2019 | By Johannes Fruehauf

  #WhereBiotechBegins   Disclaimer: the views, thoughts, and opinions expressed in this blog belong solely to the individual author,…

  Read More